Health tech startup Signos announced a $20 million funding round Wednesday, including an expanded partnership with medical device giant Dexcom.

Google Ventures, Dexcom, and Blue Cross Blue Shield of Alabama backed the round as demand for weight loss tools grows ...

The investment comes from Dexcom, Google Ventures and Blue Cross Blue Shield of Alabama, with availability to purchase the ...

Signos Inc., the company behind the first FDA-cleared, over-the-counter glucose monitoring system for weight management, today announced a $20 million funding round with investment from GV (Google ...

As it turns out, exercise is good for you. So is sleep, and unfortunately, so are vegetables. I've heard these health adages hundreds of times before, but they truly began to hit home for me this ...

Share on Pinterest The Signos system can be used alone, in combination with, or after GLP-1 drugs or bariatric surgery. Photography courtesy of Signos The FDA cleared the first glucose monitoring ...

New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. Want to lose weight but don’t want to take Ozempic ...

SAN FRANCISCO--(BUSINESS WIRE)--Today, Signos announced a first-of-its-kind 20,000 person study on the effects of combining real-time continuous glucose monitor (CGM) use and a mobile health app to ...

Signos uses continuous glucose monitors, or CGMs, and an artificial intelligence-powered app to help people better understand their metabolisms. The platform helps teach users how their daily habits ...

As it turns out, exercise is good for you. So is sleep, and unfortunately, so are vegetables. Stream San Diego News for free, 24/7, wherever you are with NBC 7. WATCH HERE I've heard these health ...